Related Experiment Video
Updated: Jan 8, 2026

10:37
A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
Published on: August 22, 2025
1.0K
Advanced Deep Learning Framework for Cancer Cell Morphological Analysis and Tumor Mutational Burden Prediction From
IEEE Journal of Biomedical and Health Informatics
|December 17, 2025
Summary
CellMorphNet predicts tumor mutational burden (TMB) from histopathology images using deep learning, offering a cost-effective alternative to sequencing for cancer immunotherapy decisions.
Area of Science:
- Computational pathology
- Artificial intelligence in oncology
- Biomarker discovery
Background:
- Cancer cell morphology analysis aids in understanding tumor behavior and treatment response.
- Tumor mutational burden (TMB) is vital for predicting immunotherapy efficacy but traditionally requires costly sequencing.
- There is a need for efficient methods to assess TMB in clinical settings.
Purpose of the Study:
- To introduce CellMorphNet, a deep learning model for predicting TMB from histopathological images.
- To develop a cost-effective and rapid method for TMB assessment.
- To integrate morphological feature extraction with attention mechanisms for accurate TMB prediction.
Main Methods:
- Developed CellMorphNet, a deep learning architecture with a four-stage hierarchical pyramid structure.
- Utilized a novel cellular deconvolution for enhanced visualization of cancer cell characteristics.
- Incorporated a hierarchical routing attention mechanism to focus on relevant cellular regions.
- Validated the model on TCGA datasets for binary and ternary TMB classification.
Main Results:
- CellMorphNet achieved high performance in binary classification (AUC 99.2%, F1-score 96.8%) and ternary classification (Accuracy 96.8%, F1-score 96.4%).
- The model demonstrated statistically significant superiority over existing methods (p<0.001).
- CellMorphNet effectively extracts relevant morphological features for TMB prediction.
Conclusions:
- CellMorphNet provides a highly accurate and efficient method for predicting TMB from histopathology images.
- This deep learning approach offers a cost-effective alternative to traditional sequencing methods.
- CellMorphNet has the potential to aid clinical decision-making in precision oncology and cancer immunotherapy.

